Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Early Per-operative Use of Polymyxin-B Hemoperfusion in Septic Patients Undergoing Emergent Abdominal Surgery

NCT01646229 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT01646229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01646229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Early Per-operative Use of Polymyxin-B Hemoperfusion in Septic Patients Undergoing Emergent Abdominal Surgery
Lead sponsor
University Hospital, Geneva
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
February 28, 2015
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal sepsis, colon perforation, peritonitis